Botulism outbreak sickens more than 50 babies and expands to all ByHeart products

Federal health officials have widened the scope of an infant botulism outbreak linked to ByHeart baby formula, now reviewing every illness reported since the company began production in 2022. At least 51 infants across 19 states have been affected, prompting a nationwide recall and new scrutiny of ByHeart’s manufacturing plants. Lab tests suggest contamination may have persisted across multiple production runs, leaving families shaken and demanding accountability. While no deaths have been reported, doctors stress that parents should stop using the formula immediately as investigations continue. Jonel Aleccia with Associated Press has the full story.

Jonel Aleccia

Associated Press

View Source